Zhang et al. confirmed that HSPA8 as a potential serum biomarker for distinguishing renal cell carcinoma from benign urologic disease with ROC area under the curve (AUC) of 0.86 [47]. This evidence concerns the gene HSPA8 and renal cell carcinoma.